DalsnaFinance › IPOs › Generate Biomedicines, Inc.
Generate Biomedicines, Inc. completed its initial public offering on NASDAQ on February 27, 2026, pricing at $16.00 a share.
| Ticker | GENB |
|---|---|
| Exchange | NASDAQ |
| Status | Completed |
| Listing date | February 27, 2026 |
| Offering price | $16.00 |
| Shares offered | 25,000,000 |
| Total raised | $400M |
IPO data is compiled from SEC filings. This page is general information, not investment advice.